VSIR and neoplasm: The addition of either anti-VISTA or anti-PSGL-1 significantly increased tumor cell killing, compared to the IgG control group (Fig. 6H), suggesting that disruption of the PSGL-1 and VISTA interaction supports a pro-cytolytic effect of OT-1 T cells on tumor cells.